Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 5,000 shares at $34.90 ($175K) on 2020-11-11, disclosed to the SEC on 2020-11-13.
Open-market sale of $174k BDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BDTX | SELL | 2021-03-04 | $65K | — | Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2021-01-06 | $140K | — | Filing → |